Cochrane is an international network of healthcare professionals, researchers and consumers producing systematic reviews of evidence. The CFGD group focuses on interventions for treating cystic fibrosis and other genetic disorders (haemoglobinopathies. coagulopathies and inborn errors of metabolism) and has its editorial base in Liverpool, UK. Our reviews all have plain language summaries to help everyone making healthcare decisions. If you are interested in working with us, please contact us.